| S7929 |
BEC HCl
|
BEC HCl is a slow-binding, and competitive arginase inhibitor with Ki of 0.31 μM (pH7.5) and 0.4-0.6 μM for Arginase II and rat Arginase I, respectively.
|
-
Cell Rep, 2024, 43(7):114490
-
J Orthop Translat, 2024, 46:53-64
-
Cancer Med, 2023, 10.1002/cam4.6627
|
|
| S9737 |
Nor-NOHA Acetate
|
Nor-NOHA acetate (Nω-Hydroxy-nor-L-Arginine acetate, N-OMega-hydroxy-L-norarginine acetate, N-Hydroxy-nor-L-arginine acetate) is a reversible, competitive inhibitor of arginase. Nor-NOHA inhibits arginase activity in aorta with an IC50 of less than 1 μM, that is, similar to its effects on liver arginase (IC50 = 0.5 μM).
|
-
Front Immunol, 2023, 14:1263646
|
|
| S6334 |
DL-Norvaline
|
DL-Norvaline (2-Aminopentanoic acid, H-DL-Nva-OH, 2-Aminovaleric acid, α-Aminopentanoic acid) is an important pharmaceutical intermediate.
|
-
Front Cell Dev Biol, 2021, 9:650819
|
|
| S3026 |
Piceatannol
|
Piceatannol, a natural stilbene, is a selective Syk inhibitor and ~10-fold selectivity versus Lyn.
|
-
Autophagy, 2025, 1-17.
-
Int J Mol Sci, 2025, 26(18)9134
-
ACS Appl Mater Interfaces, 2022, 14(21):24144-24159
|
|
| E4345 |
L-Norvaline
|
L-Norvaline is a non-proteinogenic amino acid, an isomer of valine, and an inhibitor of arginase and p70 ribosomal S6 kinase 1 (p70S6K1) kinase. L-norvaline enhances NO production from activated macrophages.
|
|
|